snapIoT and Artifact Release another mHelath Platform
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

snapIoT and Artifact Release another mHelath Platform

By Pharma Tech Outlook | Friday, May 22, 2020

Jeremy Wyatt, CTO & Senior VP

ActiGraph/snapClinical Integration advances data collection for decentralized clinical trials

FREMONT, CA: snapIoT and Actigraph reports a successful integration of the mClinical platform, snapClinical, with the support of ActiGraph’s CentrePoint System. The integration will provide sponsors and CROs an enhanced power during data collection and also insights for clinical trials.

The medical-grade wearables by ActiGraph and the cloud-based data management platform acts as an ideal, modern solution for the collection and delivery of high quality, objective points in real-time.

These validated measurements provide insight into activity intensity, steps, energy expenditure, sleep time, and sleep efficiency. snapIoT’s mClinical platform delivers patient-centric mobile solutions to facilitate the collection of surveys and ePROs (electronic Patient Reported Outcomes) as well as monitor the daily operations of decentralized clinical trials. The COVID-19 crisis has made clear the need to leverage digital technologies to sustain clinical trials and protect the health of patients when normal trial operations are interrupted. The combination of digital patient monitoring along with smart sensors provides safes and reliable methods to continue data collection via virtual outlets.

The data collected from ActiGraph’s wearables seamlessly uploads to the Cloud where snapClinical can securely retrieve and store the data. With different types of measurements being collected through the sensors, snapIoT makes visualizing data simple by creating graphs that have the flexibility to overlay data points. snapClinical also allows users to easily compare these data points with other types of collected measurements, such as surveys and diaries. Sponsors and CROs can get full insight into patients and ensure that they are engaged and compliant with the study protocol.

Actigraph, the company listed as one of the Top 10 eClinicial trial Management Solution Providers in 2017 by the Pharma Tech Outlook Magazine, and snapIoT, equipped with sophisticated and innovative technology has accomplished the integration within a week. The seamless connectivity amongst these companies also simplifies the implementation of newly validated algorithms into the systems as updates or requirements. The integration enhances the efficiency, as the sensors are installed directly into the snapClinical workflow engine. The power of snapIoT's workflow engine guarantees that the integration can be successfully done into the new study protocols with minimal effort.

 “We continue to drive more market leading wearable and sensor integrations into our snapClinical platform in record timelines to fully support decentralized clinical trials. Our partnership with ActiGraph brings an industry leading integration to Sponsors and CROs offering a greater ability to quickly deliver a patient-centric experience,” said Isaac Eteminan, CEO of snapIoT.

“We were very impressed with snapIoT’s ability to quickly develop a platform integration to address our mutual customers’ requirements. As digital endpoints have become more prevalent, we know that providing contextual insights into patient behavior in tandem with objective sensor data is crucial in establishing the baseline for our pharma clients to make definitive regulatory claims. We’re excited about future opportunities with snapIoT, and this integration is a great start,” said Jeremy Wyatt, President & COO of ActiGraph.

These are the appropriate measurements that provide insights into activity intensity, steps, energy expenditure, sleep time, and sleep efficiency. snapIoT’s mclinical platform also provides patient-centric mobile solutions that allow for the collection of surveys and ePROs (electronic Patient Reported Outcomes) along with monitoring the operations of decentralized clinical trials on a daily basis. The COVID-19 pandemic has drawn a clear picture, but unlike a conversation that needs to leverage digital technologies to sustain clinical trials and protect the health of patients during normal trial operations, When Interrupted. The combination of digital patient monitoring, along with smart sensors, provides safes and reliable methods to continue data collection via virtual outlets.

The data accumulated from ActiGraph’s wearables seamlessly upload to the Cloud, where snapClinical can securely retrieve and store the data. With different types of measurements being collected through the sensors, snapIoT makes visualizing data simply by creating graphs that have the flexibility to overlay data points. snapClinical also allows users to easily compare these data points with other types of collected measurements, such as surveys and diaries. Sponsors and CROs can get full insight into patients and ensure that they are engaged and compliant with the study protocol.

Weekly Brief

Read Also